The metabolic profile in early rheumatoid arthritis: a high prevalence of metabolic obesity

Rheumatology International

Volumn 37, Issue 1, 2017, Pages 21-27

  Müller, Raili ^a,b   Kull, Mart ^a,b   Põlluste, Kaja ^a   Aart, Annika ^a,b   Eglit, Triin ^a,b   Lember, Margus ^a,b   Kallikorm, Riina ^a,b  

^a UNIVERSITY OF TARTU   (Estonia)

^b TARTU UNIVERSITY HOSPITAL   (Estonia)

Author keywords

Early arthritis; Metabolic obesity; Metabolic syndrome; Rheumatoid arthritis

Indexed keywords

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; BODY WEIGHT; CASE CONTROL STUDY; CLINICAL EVALUATION; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ELEVATED BLOOD PRESSURE; EUROPEAN; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; ODDS RATIO; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; AGED; ARTHRITIS, RHEUMATOID; BLOOD PRESSURE; COMORBIDITY; CROSS-SECTIONAL STUDY; DISEASE COURSE; PHYSIOLOGY;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BLOOD PRESSURE; COMORBIDITY; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREVALENCE;

EID: 84963741677     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-016-3464-9     Document Type: Article

References (44)

1. Dadoun S, Zeboulon-Ktorza N, Combescure C et al (2013) Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis. Jt Bone Spine Rev Rhum 80:29–33. doi:10.1016/j.jbspin.2012.02.005
2. Puttevils D, De Vusser P, Geusens P, Dens J (2014) Increased cardiovascular risk in patients with rheumatoid arthritis: an overview. Acta Cardiol 69:111–118
3. Peters MJL, Symmons DPM, McCarey D et al (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69:325–331
4. Meune C, Touzé E, Trinquart L, Allanore Y (2009) Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. Rheumatology 48:1309–1313. doi:10.1093/rheumatology/kep252
5. Levi F, Chatenoud L, Bertuccio P et al (2009) Mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world: an update. Eur J Cardiovasc Prev Rehabil 16:333–350. doi:10.1097/HJR.0b013e328325d67d
6. Nichols M, Townsend N, Scarborough P, Rayner M (2013) Trends in age-specific coronary heart disease mortality in the European Union over three decades: 1980–2009. Eur Heart J. doi:10.1093/eurheartj/eht159
7. Gonzalez A, Maradit Kremers H, Crowson CS et al (2007) The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum 56:3583–3587. doi:10.1002/art.22979
8. Humphreys JH, Warner A, Chipping J et al (2014) Mortality trends in patients with early rheumatoid arthritis over 20 years: results from the norfolk arthritis register: trends of mortality rates in UK patients with early RA. Arthritis Care Res 66:1296–1301. doi:10.1002/acr.22296
9. Goodson NJ, Wiles NJ, Lunt M et al (2002) Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum 46:2010–2019. doi:10.1002/art.10419
10. Lacaille D, Sayre EC, Abrahamowicz M (2015) Improvement in mortality in RA compared to the general population—closing the mortality gap (abstract). Arthritis Rheumatol 67 (suppl 10)
11. Markusse IM, Dirven L, van Groenendael JH et al (2014) Mortality in a large cohort of patients with early rheumatoid arthritis that were treated-to-target for 10 years (abstract). Arthritis Rheumatol 66 (Suppl 11)
12. Gonzalez A, Maradit Kremers H, Crowson CS et al (2008) Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? Ann Rheum Dis 67:64–69. doi:10.1136/ard.2006.059980
13. Del Rincón I, Williams K, Stern MP et al (2001) High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 44:2737–2745. doi:10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#
14. Ferraz-Amaro I, González-Juanatey C, López-Mejias R et al (2013) Metabolic syndrome in rheumatoid arthritis. Mediat Inflamm. doi:10.1155/2013/710928
15. (2002) Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 106:3143–3143
16. Grundy SM, Brewer HB, Cleeman JI et al (2004) Definition of metabolic syndrome report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on scientific issues related to definition. Circulation 109:433–438. doi: 10.1161/01.CIR.0000111245.75752.C6
17. Zhang J, Fu L, Shi J et al (2013) The risk of metabolic syndrome in patients with rheumatoid arthritis: a meta-analysis of observational studies. PLoS One 8:e78151. doi:10.1371/journal.pone.0078151
18. Chung CP, Oeser A, Solus JF et al (2008) Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis 196:756–763. doi:10.1016/j.atherosclerosis.2007.01.004
19. da Cunha VR, Brenol CV, Brenol JCT et al (2012) Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity. Scand J Rheumatol 41:186–191. doi:10.3109/03009742.2011.626443
20. Crowson CS, Myasoedova E, Davis JM et al (2011) Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease. J Rheumatol 38:29–35. doi:10.3899/jrheum.100346
21. Abourazzak FE, Mansouri S, Najdi A et al (2014) Prevalence of metabolic syndrome in patients with rheumatoid arthritis in Morocco: a cross-sectional study of 179 cases. Clin Rheumatol 33:1549–1555. doi:10.1007/s10067-014-2570-x
22. Kerekes G, Nurmohamed MT, González-Gay MA et al (2014) Rheumatoid arthritis and metabolic syndrome. Nat Rev Rheumatol 10:691–696. doi:10.1038/nrrheum.2014.121
23. Mok CC, Ko GTC, Ho LY et al (2011) Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis. Arthritis Care Res 63:195–202. doi:10.1002/acr.20363
24. Karimi M, Mazloomzadeh S, Kafan S, Amirmoghadami H (2011) The frequency of metabolic syndrome in women with rheumatoid arthritis and in controls. Int J Rheum Dis 14:248–254. doi:10.1111/j.1756-185X.2011.01595.x
25. Sahebari M, Goshayeshi L, Mirfeizi Z et al (2011) Investigation of the association between metabolic syndrome and disease activity in rheumatoid arthritis. Sci World J 11:1195–1205. doi:10.1100/tsw.2011.111
26. Šalamon L, Morović-Vergles J, Marasović-Krstulović D et al (2015) Differences in the prevalence and characteristics of metabolic syndrome in rheumatoid arthritis and osteoarthritis: a multicentric study. Rheumatol Int. doi:10.1007/s00296-015-3307-0
27. Mathew H, Farr OM, Mantzoros CS (2016) Metabolic health and weight: understanding metabolically unhealthy normal weight or metabolically healthy obese patients. Metabolism 65:73–80. doi:10.1016/j.metabol.2015.10.019
28. St-Onge M-P, Janssen I, Heymsfield SB (2004) Metabolic syndrome in normal-weight americans new definition of the metabolically obese, normal-weight individual. Diabetes Care 27:2222–2228. doi:10.2337/diacare.27.9.2222
29. Giles JT, Allison M, Blumenthal RS et al (2010) Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics. Arthritis Rheum 62:3173–3182. doi:10.1002/art.27629
30. Elkan A-C, Håkansson N, Frostegård J et al (2009) Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther 11:R37. doi:10.1186/ar2643
31. Book C, Karlsson MK, Åkesson K, Jacobsson LTH (2009) Early rheumatoid arthritis and body composition. Rheumatology 48:1128–1132. doi:10.1093/rheumatology/kep165
32. Book C, Karlsson M, Nilsson J-Å et al (2011) Changes in body composition after 2 years with rheumatoid arthritis. Scand J Rheumatol 40:95–100. doi:10.3109/03009742.2010.507215
33. Wilson PF, D’Agostino RB, Sullivan L et al (2002) Overweight and obesity as determinants of cardiovascular risk: the framingham experience. Arch Intern Med 162:1867–1872. doi:10.1001/archinte.162.16.1867
34. Escalante A, Haas RW, del Rincón I (2005) Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch Intern Med 165:1624–1629. doi:10.1001/archinte.165.14.1624
35. Kremers HM, Nicola PJ, Crowson CS et al (2004) Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis. Arthritis Rheum 50:3450–3457. doi:10.1002/art.20612
36. Dao H-H, Do Q-T, Sakamoto J (2010) Increased frequency of metabolic syndrome among Vietnamese women with early rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther 12:R218. doi:10.1186/ar3203
37. Parra-Salcedo F, Contreras-Yáñez I, Elías-López D et al (2015) Prevalence, incidence and characteristics of the metabolic syndrome (MetS) in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease modifying anti-rheumatic drugs: the complex relationship between MetS and disease activity. Arthritis Res Ther 17:34. doi:10.1186/s13075-015-0549-x
38. Eglit T, Rajasalu T, Lember M (2012) Metabolic syndrome in estonia: prevalence and associations with insulin resistance. Int J Endocrinol. doi:10.1155/2012/951672
39. van Gestel AM, Haagsma CJ, van Riel PL (1998) Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 41:1845–1850. doi:10.1002/1529-0131(199810)41:10<1845:AID-ART17>3.0.CO;2-K
40. World Health Organization (1997) Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity, 3–5 June 1997, WHO/NUT/NCD/98.1. WHO, Geneva
41. Eckel N, Mühlenbruch K, Meidtner K et al (2015) Characterization of metabolically unhealthy normal-weight individuals: risk factors and their associations with type 2 diabetes. Metabolism 64:862–871. doi:10.1016/j.metabol.2015.03.009
42. Sattar N, McCarey DW, Capell H, McInnes IB (2003) Explaining how “high-grade” systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 108:2957–2963. doi:10.1161/01.CIR.0000099844.31524.05
43. Morović-Vergles J, Salamon L, Marasović-Krstulović D et al (2013) Is the prevalence of arterial hypertension in rheumatoid arthritis and osteoarthritis associated with disease? Rheumatol Int 33:1185–1192. doi:10.1007/s00296-012-2522-1
44. Panoulas VF, Metsios GS, Pace AV et al (2008) Hypertension in rheumatoid arthritis. Rheumatology 47:1286–1298. doi:10.1093/rheumatology/ken159